[HTML][HTML] Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?

AR Yoon, JW Hong, BK Jung, H Ahn, S Zhang, CO Yun - Cancer Letters, 2023 - Elsevier
Pancreatic cancer remains one of the deadliest cancers with extremely high mortality rate,
and the number of cases is expected to steadily increase with time. Pancreatic cancer is …

[HTML][HTML] Beyond COVID-19: the promise of next-generation coronavirus vaccines

R Koolaparambil Mukesh, CK Yinda, VJ Munster… - npj Viruses, 2024 - nature.com
Coronaviruses (CoVs) have caused three global outbreaks: severe acute respiratory
syndrome coronavirus 1 (SARS-CoV-1) in 2003, Middle East respiratory syndrome …

Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2

J Huang, W Wang, H Li, Y Bai, Y Song, C Jiao, H Jin… - Antiviral Research, 2024 - Elsevier
The rapid emergence of Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-
CoV-2) variants, coupled with severe immune evasion and imprinting, has jeopardized the …

[HTML][HTML] Recombinant vaccines: Current updates and future prospects

V Kumar, A Verma, R Singh, P Garg… - Asian Pacific Journal …, 2024 - journals.lww.com
Recombinant technology-based vaccines have emerged as a highly effective way to prevent
a wide range of illnesses. The technology improved vaccine manufacturing, rendering it …

[HTML][HTML] Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and …

X Han, M Wei, X Zheng, P Wan, J Tang, L Zhang… - Vaccines, 2024 - mdpi.com
Background: Though children infected by SARS-CoV-2 generally experience milder
symptoms compared to adults, severe cases can occur. Additionally, children can transmit …